How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Self-citationNutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
“(177,178)din people undergoingweight loss treatment.”
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Self-citationRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0236 · Cited by 1,008
“0%, respectively, off all diabetes medications, and maintenance of these glycemic levels for at least 1 year (97).”
BackgroundSelf-citationSalminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., Hurme, S., Soinio, M., Nuutila, P., & Victorzon, M. (2018) · JAMA · doi:10.1001/jama.2017.20313 · Cited by 946
Courcoulas, A. P. (2013) · JAMA · doi:10.1001/jama.2013.280928 · Cited by 799
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders—European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO), Fried, M., Yumuk, V., Oppert, J. M., Scopinaro, N., Torres, A., Weiner, R., Yashkov, Y., & Frühbeck, G. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1079-8 · Cited by 753
“In case of T2DM patients, use of anti-diabetic medication and/ or insulin should be with no delays adjusted post-operatively to minimize risks of hypoglycaemia.”
BackgroundInfluentialAssociation of an intensive lifestyle intervention with remission of type 2 diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.67929 · Cited by 752
“The appropriate definition of diabetes remission remains an area of ambiguity and debate.(9) For these analyses, we adopted the American Diabetes Association’s definition, achievement of glycemia below the diabetic range in the absence of active pharmacological treatment or surgical therapy.”
Health benefits of gastric bypass surgery after 6 years
Adams, T. D., Davidson, L. E., Litwin, S. E., Kolotkin, R. L., LaMonte, M. J., Pendleton, R. C., Strong, M. B., Vinik, R., Wanner, N. A., Hopkins, P. N., et al. (2012) · JAMA · doi:10.1001/2012.jama.11164 · Cited by 674
“High LDL-C 9/334 3 (1-5) 13/328 4 (1-7) 38/321 12 (7-17) 66/265 25 (18-32) 44/248 18 (12-24) 71/237 30 (22-38)”
InfluentialMechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Lingvay, I., Sumithran, P., Cohen, R. V., & le Roux, C. W. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01919-x · Cited by 581
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., Chamseddine, G., Bornstein, S. R., & Rubino, F. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32649-0 · Cited by 577
Self-citationBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552
Management of type 2 diabetes: new and future developments in treatment
Tahrani, A. A., Bailey, C. J., Del Prato, S., & Barnett, A. H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60207-9 · Cited by 533
Dietary and nutritional approaches for prevention and management of type 2 diabetes
Forouhi, N. G., Misra, A., Mohan, V., Taylor, R., & Yancy, W. (2018) · BMJ · doi:10.1136/bmj.k2234 · Cited by 472
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Consensus report: definition and interpretation of remission in type 2 diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0034 · Cited by 464
“Although the previous consensus statement suggested dividing diabetes remission into partial and complete categories, using different glycemic thresholds (16), this distinction could introduce ambiguity affecting policy decisions related to insurance premiums, reimbursements, and coding of medical encounters.”
InfluentialSelf-citationBusetto, L., Dicker, D., Azran, C., Batterham, R. L., Farpour-Lambert, N., Fried, M., Hjelmesæth, J., Kinzl, J., Leitner, D. R., Makaronidis, J. M., et al. (2017) · Obesity Facts · doi:10.1159/000481825 · Cited by 437
“For patients in good metabolic control and not requiring glucose-lowering medications after surgery (complete diabetes remission), treatment goals for co-morbid conditions and screening for microvascular complications should be the same as those for patients with diabetes [49] .”
BackgroundGoldenberg, J. Z., Day, A., Brinkworth, G. D., Sato, J., Yamada, S., Jönsson, T., Beardsley, J., Johnson, J. A., Thabane, L., & Johnston, B. C. (2021) · BMJ · doi:10.1136/bmj.m4743 · Cited by 428
Arterburn, D. E., Bogart, A., Sherwood, N. E., Sidney, S., Coleman, K. J., Haneuse, S., O’Connor, P. J., Theis, M. K., Campos, G. M., McCulloch, D., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0802-1 · Cited by 426
“This is likely due to our use of the recent, consensus-based, but relatively conservative definition of diabetes remission [22], and our reliance on electronic medical record data to identify clinical laboratory evidence of glycemic control occurring ≥90 days after the end of the last filled diabetes medication prescr…”
InfluentialShariq, O. A., & McKenzie, T. J. (2020) · Gland Surgery · doi:10.21037/gs.2019.12.03 · Cited by 359
Mechanick, J. I., Apovian, C., Brethauer, S., Timothy Garvey, W., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 389
Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418
Courcoulas, A. P., Belle, S. H., Neiberg, R. H., Pierson, S. K., Eagleton, J. K., Kalarchian, M. A., DeLany, J. P., Lang, W., & Jakicic, J. M. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.1534 · Cited by 376
Still, C. D., Wood, G. C., Benotti, P., Petrick, A. T., Gabrielsen, J., Strodel, W. E., Ibele, A., Seiler, J., Irving, B. A., Celaya, M. P., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70070-6 · Cited by 350
The gut microbiome, diet, and links to cardiometabolic and chronic disorders
Aron-Wisnewsky, J., & Clément, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.191 · Cited by 325
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
Fried, M., Yumuk, V., Oppert, J.-M., Scopinaro, N., Torres, A. J., Weiner, R., Yashkov, Y., & Frühbeck, G. (2013) · Obesity Facts · doi:10.1159/000355480 · Cited by 316
Athinarayanan, S. J., Adams, R. N., Hallberg, S. J., McKenzie, A. L., Bhanpuri, N. H., Campbell, W. W., Volek, J. S., Phinney, S. D., & McCarter, J. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00348 · Cited by 324
Cummings, D. E., Arterburn, D. E., Westbrook, E. O., Kuzma, J. N., Stewart, S. D., Chan, C. P., Bock, S. N., Landers, J. T., Kratz, M., Foster-Schubert, K. E., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3903-x · Cited by 314
“5 mmol/mol], respectively, off diabetes medications [27]), although results from other studies vary widely depending on differences in these thresholds [33].”
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
Madsbad, S., Dirksen, C., & Holst, J. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70218-3 · Cited by 298
Bariatric surgery for type 2 diabetes
Dixon, J. B., le Roux, C. W., Rubino, F., & Zimmet, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60401-2 · Cited by 296
Self-citationDevelopment of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Ikramuddin, S., Korner, J., Lee, W.-J., Thomas, A. J., Connett, J. E., Bantle, J. P., Leslie, D. B., Wang, Q., Inabnet, W. B., Jeffery, R. W., et al. (2018) · JAMA · doi:10.1001/jama.2017.20813 · Cited by 291
“Triple End Point 1 16 (8 to 31) 50 (34 to 66) 34 (14-54) 5.”
Murphy, R., Tsai, P., Jüllig, M., Liu, A., Plank, L., & Booth, M. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2399-2 · Cited by 285
“5 %), in the absence of glucose lowering therapy [19].”
BackgroundLong-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes
Courcoulas, A. P., Patti, M. E., Hu, B., Arterburn, D. E., Simonson, D. C., Gourash, W. F., Jakicic, J. M., Vernon, A. H., Beck, G. J., Schauer, P. R., et al. (2024) · JAMA · doi:10.1001/jama.2024.0318 · Cited by 284
The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones
Meek, C. L., Lewis, H. B., Reimann, F., Gribble, F. M., & Park, A. J. (2016) · Peptides · doi:10.1016/j.peptides.2015.08.013 · Cited by 269
Sharaiha, R. Z., Kumta, N. A., Saumoy, M., Desai, A. P., Sarkisian, A. M., Benevenuto, A., Tyberg, A., Kumar, R., Igel, L., Verna, E. C., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.12.012 · Cited by 268
Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity
Aminian, A., Brethauer, S. A., Andalib, A., Nowacki, A. S., Jimenez, A., Corcelles, R., Hanipah, Z. N., Punchai, S., Bhatt, D. L., Kashyap, S. R., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002407 · Cited by 256
Expert panel report: Guidelines (2013) for the management of overweight and obesity in adults
(2014) · Obesity · doi:10.1002/oby.20660 · Cited by 257
Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score
Lee, W.-J., Hur, K. Y., Lakadawala, M., Kasama, K., Wong, S. K. H., Chen, S.-C., Lee, Y.-C., & Ser, K.-H. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.07.015 · Cited by 250
Peterli, R., Wölnerhanssen, B. K., Vetter, D., Nett, P., Gass, M., Borbély, Y., Peters, T., Schiesser, M., Schultes, B., Beglinger, C., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001929 · Cited by 247
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass
Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Jacobsen, S. H., Hansen, D. L., Worm, D., Holst, J. J., & Madsbad, S. (2012) · Diabetologia · doi:10.1007/s00125-012-2556-7 · Cited by 239
Jiménez, A., Casamitjana, R., Flores, L., Viaplana, J., Corcelles, R., Lacy, A., & Vidal, J. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318262ee6b · Cited by 237
McTigue, K. M., Wellman, R., Nauman, E., Anau, J., Coley, R. Y., Odor, A., Tice, J., Coleman, K. J., Courcoulas, A., Pardee, R. E., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.0087 · Cited by 229
Trastulli, S., Desiderio, J., Guarino, S., Cirocchi, R., Scalercio, V., Noya, G., & Parisi, A. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.05.007 · Cited by 231
Risstad, H., Søvik, T. T., Engström, M., Aasheim, E. T., Fagerland, M. W., Olsén, M. F., Kristinsson, J. A., le Roux, C. W., Bøhmer, T., Birkeland, K. I., et al. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.3579 · Cited by 229
Surgical vs Medical Treatments for Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Courcoulas, A. P., Goodpaster, B. H., Eagleton, J. K., Belle, S. H., Kalarchian, M. A., Lang, W., Toledo, F. G. S., & Jakicic, J. M. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.467 · Cited by 225
Gerhard, G. S., Styer, A. M., Wood, G. C., Roesch, S. L., Petrick, A. T., Gabrielsen, J., Strodel, W. E., Still, C. D., & Argyropoulos, G. (2013) · Diabetes Care · doi:10.2337/dc12-2255 · Cited by 220
“Three groups of RYGB patients were used for this study: 1) a control group that did not have diabetes before or after surgery (No-Diabetes), 2) a group that had diabetes before surgery but experienced complete remission (17) for at least 12 months after surgery (Diabetes-R), and 3) a group that had diabetes before sur…”
BackgroundMethodHofsø, D., Nordstrand, N., Johnson, L. K., Karlsen, T. I., Hager, H., Jenssen, T., Bollerslev, J., Godang, K., Sandbu, R., Røislien, J., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0514 · Cited by 207
Hofsø, D., Fatima, F., Borgeraas, H., Birkeland, K. I., Gulseth, H. L., Hertel, J. K., Johnson, L. K., Lindberg, M., Nordstrand, N., Cvancarova Småstuen, M., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30344-4 · Cited by 201
Dedov, I. I., Mel'nichenko, G. A., Shestakova, M. V., Troshina, E. A., Mazurina, N. V., Shestakova, E. A., Yashkov, Y. I., Neimark, A. E., Biryukova, E. V., Bondarenko, I. Z., et al. (2018) · Obesity and metabolism · doi:10.14341/omet2018153-70 · Cited by 173
Ikramuddin, S., Billington, C. J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Jeffery, R. W., Chong, K., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00089-3 · Cited by 207
Esposito, K., Maiorino, M. I., Petrizzo, M., Bellastella, G., & Giugliano, D. (2014) · Diabetes Care · doi:10.2337/dc13-2899 · Cited by 205
“Moreover, the appropriate definition of diabetes remission remains an area of ambiguity and debate (28).”
BackgroundChuruangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J. (2022) · Diabetologia · doi:10.1007/s00125-021-05577-2 · Cited by 204
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Summit, O. B. O. T. D. O. T. 2. D. S., Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2457-9 · Cited by 189
Self-citationComparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents
Inge, T. H., Laffel, L. M., Jenkins, T. M., Marcus, M. D., Leibel, N. I., Brandt, M. L., Haymond, M., Urbina, E. M., Dolan, L. M., Zeitler, P. S., et al. (2018) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.5763 · Cited by 189
Christensen, P., Meinert Larsen, T., Westerterp‐Plantenga, M., Macdonald, I., Martinez, J. A., Handjiev, S., Poppitt, S., Hansen, S., Ritz, C., Astrup, A., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13466 · Cited by 188
Pournaras, D. J., Aasheim, E. T., Søvik, T. T., Andrews, R., Mahon, D., Welbourn, R., Olbers, T., & le Roux, C. W. (2012) · Journal of British Surgery · doi:10.1002/bjs.7704 · Cited by 181
Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy
Golomb, I., Ben David, M., Glass, A., Kolitz, T., & Keidar, A. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.2202 · Cited by 177
Courcoulas, A. P., Gallagher, J. W., Neiberg, R. H., Eagleton, E. B., DeLany, J. P., Lang, W., Punchai, S., Gourash, W., & Jakicic, J. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa006 · Cited by 180
Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients
Sánchez-Pernaute, A., Rubio, M. Á., Cabrerizo, L., Ramos-Levi, A., Pérez-Aguirre, E., & Torres, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.01.024 · Cited by 174
Reversing Type 2 Diabetes: A Narrative Review of the Evidence
Hallberg, S. J., Gershuni, V. M., Hazbun, T. L., & Athinarayanan, S. J. (2019) · Nutrients · doi:10.3390/nu11040766 · Cited by 170
The role of bariatric surgery to treat diabetes: current challenges and perspectives
Koliaki, C., Liatis, S., le Roux, C. W., & Kokkinos, A. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0202-6 · Cited by 167
“5% off antidiabetic medication for at least 1 year [15, 25].”
BackgroundWölnerhanssen, B. K., Peterli, R., Hurme, S., Bueter, M., Helmiö, M., Juuti, A., Meyer-Gerspach, A. C., Slawik, M., Peromaa-Haavisto, P., Nuutila, P., et al. (2021) · British Journal of Surgery · doi:10.1093/bjs/znaa011 · Cited by 160
Lee, W.-J., Chen, C.-Y., Chong, K., Lee, Y.-C., Chen, S.-C., & Lee, S.-D. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.07.009 · Cited by 164
Cohen, R. V., Pereira, T. V., Aboud, C. M., Petry, T. B. Z., Lopes Correa, J. L., Schiavon, C. A., Pompílio, C. E., Pechy, F. N. Q., da Costa Silva, A. C. C., de Melo, F. L. G., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.0420 · Cited by 156
Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.05.018 · Cited by 157
“0%, respectively, off all diabetes medications, and maintenance of these glycemic levels for at least 1 year (97).”
Self-citationHall, T. C., Pellen, M., Sedman, P. C., & Jain, P. K. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0198-8 · Cited by 158
Ahuja, A., Tantia, O., Goyal, G., Chaudhuri, T., Khanna, S., Poddar, A., Gupta, S., & Majumdar, K. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3405-7 · Cited by 154
Long-term results after sleeve gastrectomy: A systematic review
Juodeikis, Ž., & Brimas, G. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.10.006 · Cited by 149
Debédat, J., Sokolovska, N., Coupaye, M., Panunzi, S., Chakaroun, R., Genser, L., de Turenne, G., Bouillot, J.-L., Poitou, C., Oppert, J.-M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0567 · Cited by 138
“DR is defined by fasting plasma glucose (FPG) and HbA1c normalization (,7 mmol/L and,6% [42 mmol/ mol], respectively) without any glucoselowering medication at 1 year post-BS (5).”
BackgroundMethodInfluentialNoninvasive Electromagnetic Wave Sensing of Glucose
Zhang, R., Liu, S., Jin, H., Luo, Y., Zheng, Z., Gao, F., & Zheng, Y. (2019) · Sensors · doi:10.3390/s19051151 · Cited by 153
“Since there is no specific remission or cure of diabetes [26], daily glycemic measures need to be carried out together with active treatments (insulin injection or bariatric surgery) to improve the lives of diabetic patients.”
BackgroundAron‐Wisnewsky, J., Sokolovska, N., Liu, Y., Comaneshter, D. S., Vinker, S., Pecht, T., Poitou, C., Oppert, J., Bouillot, J., Genser, L., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4371-7 · Cited by 154
Effects of Bilio-Pancreatic Diversion on Diabetic Complications
Iaconelli, A., Panunzi, S., De Gaetano, A., Manco, M., Guidone, C., Leccesi, L., Gniuli, D., Nanni, G., Castagneto, M., Ghirlanda, G., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1761 · Cited by 141
“Recently, an agreement was reached about the definition of the effect of metabolic surgery on diabetes (17), with “remission” defined as the achievement of glycemia below the diabetes range in the absence of active pharmacological or additional surgical therapy.”
BackgroundSchmidt, S. K., Hemmestad, L., MacDonald, C. S., Langberg, H., & Valentiner, L. S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207454 · Cited by 140
Bariatric Surgery in the Treatment of Type 2 Diabetes
Affinati, A. H., Esfandiari, N. H., Oral, E. A., & Kraftson, A. T. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1269-4 · Cited by 158
Purnell, J. Q., Selzer, F., Wahed, A. S., Pender, J., Pories, W., Pomp, A., Dakin, G., Mitchell, J., Garcia, L., Staten, M. A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2138 · Cited by 135
“9 mmol/L if HbA1c was not available) and an absence of active pharmacologic therapy for diabetes (10).”
BackgroundJirapinyo, P., Haas, A. V., & Thompson, C. C. (2018) · Diabetes Care · doi:10.2337/dc17-1985 · Cited by 134
“acute pancreatitis (6), sleeve migration”
Kalinowski, P., Paluszkiewicz, R., Wróblewski, T., Remiszewski, P., Grodzicki, M., Bartoszewicz, Z., & Krawczyk, M. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.08.025 · Cited by 142
Metabolic and Endocrine Consequences of Bariatric Surgery
Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00626 · Cited by 145
Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study
Karter, A. J., Nundy, S., Parker, M. M., Moffet, H. H., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc14-0874 · Cited by 132
“As discussed above, the appropriate definitions of diabetes remission remain an area of considerable debate (10), which this study seeks to partially inform.”
BackgroundMethodInfluentialBariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2
Cummings, D. E., & Cohen, R. V. (2016) · Diabetes Care · doi:10.2337/dc16-0350 · Cited by 124
“tes “remission” have been published by prominent authorities (30).”
BackgroundCarlsson, L. M. S., Sjöholm, K., Karlsson, C., Jacobson, P., Andersson-Assarsson, J. C., Svensson, P.-A., Larsson, I., Hjorth, S., Neovius, M., Taube, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30061-x · Cited by 126
BARIA-MAT Group, Ciangura, C., Coupaye, M., Deruelle, P., Gascoin-Lachambre, G., Calabrese, D., Cosson, E., Ducarme, G., Gaborit, B., Lelièvre, B., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04093-y · Cited by 143
Yip, S., Plank, L. D., & Murphy, R. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1030-z · Cited by 145
“Additionally, they defined prolonged remission if these conditions were met for at least 5 years [30].”
BackgroundImpact of feature scaling on machine learning models for the diagnosis of diabetes
Ozsahin, D. U., Mustapha, M. T., Mubarak, A. S., Ameen, Z. S., & Uzun, B. (2022) · International Conference on Artificial Intelligence in Everything (AIE) · doi:10.1109/aie57029.2022.00024 · Cited by 128
Blackstone, R. P., Bunt, J. C., Cortés, M. C., & Sugerman, H. J. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.05.005 · Cited by 135
Late Relapse of Diabetes After Bariatric Surgery: Not Rare, but Not a Failure
Aminian, A., Vidal, J., Salminen, P., Still, C. D., Nor Hanipah, Z., Sharma, G., Tu, C., Wood, G. C., Ibarzabal, A., Jimenez, A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1057 · Cited by 122
“© 2020 by the American Diabetes Association.”
MethodInfluentialMusella, M., Apers, J. A., Rheinwalt, K. P., Ribeiro, R. J. D. S., Manno, E., Greco, F., Čierny, M., Milone, M., Stefano, C. D., Güler, S., et al. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1865-6 · Cited by 128
Consensus report: definition and interpretation of remission in type 2 diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05542-z · Cited by 127
Self-citationNovikov, A. A., Afaneh, C. I., Saumoy, M., Parra, V., Shukla, A. P., Dakin, G. F., Pomp, A., Dawod, E., Shah, S. M., Aronne, L. J., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3615-7 · Cited by 128
Jiménez, A., Casamitjana, R., Viaplana-Masclans, J., Lacy, A., & Vidal, J. (2013) · Diabetes Care · doi:10.2337/dc12-1535 · Cited by 123
“0% in the absence of active pharmacological therapy and lasting at least 1 year (21).”
BackgroundAminian, A., Brethauer, S. A., Andalib, A., Punchai, S., Mackey, J., Rodriguez, J., Rogula, T., Kroh, M., & Schauer, P. R. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001857 · Cited by 113
Shamanna, P., Saboo, B., Damodharan, S., Mohammed, J., Mohamed, M., Poon, T., Kleinman, N., & Thajudeen, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00931-w · Cited by 115
“[19], 40% of patients reached FBG\126 mg/dl (the threshold for partial remission of diabetes [24]) at 10 weeks when isocaloric eating was resumed, and 43% of patients continued to have FBG\126 mg/dl at 6 months.”
BackgroundLaparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score
Lee, W., Almulaifi, A. M., Tsou, J. J., Ser, K., Lee, Y.-C., & Chen, S. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.027 · Cited by 121
Madsen, L. R., Baggesen, L. M., Richelsen, B., & Thomsen, R. W. (2019) · Diabetologia · doi:10.1007/s00125-019-4816-2 · Cited by 125
Borgeraas, H., Hofsø, D., Hertel, J. K., & Hjelmesaeth, J. S. (2020) · Obesity Reviews · doi:10.1111/obr.13011 · Cited by 122
Coleman, K. J., Haneuse, S., Johnson, E., Bogart, A., Fisher, D., O’Connor, P. J., Sherwood, N. E., Sidney, S., Theis, M. K., Anau, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0194 · Cited by 107
“5%/48 mmol/mol after being off all type 2 diabetes medications for $90 days and/or 2) fasting glucose ,126 mg/dL after being off all type 2 diabetes medications for $7 days (16).”
BackgroundLSG vs OAGB—1 Year Follow-up Data—a Randomized Control Trial
Seetharamaiah, S., Tantia, O., Goyal, G., Chaudhuri, T., Khanna, S., Singh, J. P., & Ahuja, A. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2403-x · Cited by 114
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.